Publications in collaboration with researchers from Sarah Cannon Research Institute (2)

2023

  1. Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in NRAS -Mutant Melanoma: Results From the Expansion Arm of a Phase Ib, Open-Label Study

    Journal of Clinical Oncology, Vol. 41, Núm. 14, pp. 2651-2660

2022

  1. MCLA-129, a human anti-EGFR and anti-c-MET bispecific antibody, in patients with advanced NSCLC and other solid tumors: an ongoing phase 1/2 study

    European Journal of Cancer, Vol. 174, pp. S122